VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer

NCT01486329 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IV Pancreatic Cancer

Interventions

BIOLOGICAL: VXM01
BIOLOGICAL: Placebo

Sponsor

Vaximm GmbH